| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |